Marker Therapeutics Inc
MRKR
|
|
| |
|
| Trading Volume | 149,671 |
|
|
0.00 - 0.00 |
| Market Cap Full | $ 3.1M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | - | - | 34.2% | -53.7% |
| Q2 | - | - | - | -25% |
| Q3 | - | - | - | 12.1% |
| Q4 | - | - | - | -28.9% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2023 | |||||||||||
| 34.2 | - | - | - | - | - | - | - | - | - | - | - |
| 2022 | |||||||||||
| -35.8 | -38 | 16.4 | -23 | -14.2 | 13.4 | -1.2 | -4.9 | 19.4 | 18.9 | -31.8 | -12.3 |
| 2021 | |||||||||||
| 28 | 32.3 | -13.4 | 16.4 | 13.7 | -4.1 | -23.7 | -7 | -13.4 | -12.5 | -21.3 | -19.5 |
| 2020 | |||||||||||
| -14.8 | -2.7 | -24.9 | 45 | -17.6 | -8.8 | -2.9 | -10.5 | -16.7 | -9.3 | 25 | -11.8 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.6 | -1.2 | -0.2 | -0.1 |
| Q2 | 0.3 | -1.1 | -0.1 | -0.1 |
| Q3 | -0.3 | -0.8 | -0.2 | -0.2 |
| Q4 | 0 | -0.5 | -1.1 | -0.2 |
| A | -0.62 | -3.6 | -5.5 | -0.6 |